Keyphrases
Next-generation Sequencing
100%
Prostate Cancer
100%
Tumor Targeting
100%
Methylthioadenosine Phosphorylase
100%
Tumor
33%
Prostate Tumor
33%
Genome Sequencing
33%
Xenograft
33%
6-Thioguanine (6-TG)
33%
Patient-derived Xenograft
16%
High Dose
16%
Patient-derived
16%
Poor Outcome
16%
Therapeutic Approaches
16%
Therapeutic Agents
16%
Neuroendocrine Carcinoma
16%
Hypermethylation
16%
Prostate Carcinoma
16%
Human Cancer
16%
Fatal Infection
16%
Prognosticator
16%
Patient Tumor
16%
Illumina
16%
Tumor Xenograft
16%
Castration-resistant Prostate Cancer
16%
Palliative Therapy
16%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
16%
Tumor Sequencing
16%
Renal Capsule
16%
Primary Prostate Cancer
16%
Personalized Oncology
16%
ARF Gene
16%
9p21 Deletion
16%
Methylthioadenosine
16%
Medicine and Dentistry
Neoplasm
100%
Prostate Cancer
100%
Next Generation Sequencing
100%
5' Methylthioadenosine Phosphorylase
100%
Xenograft
50%
Genome Sequencing
33%
Prostate Tumor
33%
Tioguanine
33%
Cancer
16%
Drug Megadose
16%
Tumor
16%
Therapeutic Agent
16%
Oncology
16%
Neuroendocrine Carcinoma
16%
Tumor Xenograft
16%
Messenger RNA
16%
Diseases
16%
Biochemistry, Genetics and Molecular Biology
Next Generation Sequencing
100%
Phosphorylase
100%
Deficiency
100%
Genome Sequencing
33%
Tioguanine
33%
Drug Megadose
16%
Messenger RNA
16%